Drug Trial Radar · NCT01388933
A Safety and Efficacy Study of Daikenchuto (TU-100) to Treat Crohn's Disease
Last checked: Nov 19, 2026Latest source record: Jun 11, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
79
Actual
Start
Sep 2011
Primary completion
Sep 2013
Study completion Sep 2013
Sponsor
- Lead sponsor
- Tsumura USAIndustry
- Sponsor type
- Industry
- Collaborators
- Syneos Health
- First posted
- Jul 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether Daikenchuto(TU-100)is effective in the treatment of Crohn's disease.
Conditions
- Crohn's Disease
Interventions
TU-100Drug
15g daily, orally as 5g three times daily for 8 consecutive weeks
Matching PlaceboDrug
15g as 5g three times daily, orally for 8 consecutive weeks
Primary outcomes
What the sponsor says the trial is designed to measure.
- Clinical response as measured by a reduction in the CDAI total scoreTime frame: over eight weeks
Locations
27 sites in 1 country. Site status is shown where the registry gives one.
Preferred Research Partners Inc
Little Rock, Arkansas
TRIMED Clinical Trials
Corona, California
Digestive Care Associates, LLC
San Carlos, California
University of California at San Francisco
San Francisco, California
Rocky Mountain Gastroenterology Associates
Lakewood, Colorado
Clinical Research of West Florida, Inc
Clearwater, Florida
Gastroenterology Group of Naples
Naples, Florida
Shafran Gastroenterology Center
Winter Park, Florida
Atlanta Gastroenterology Associates, LLC
Atlanta, Georgia
Gastroenterology Associates of Central Georgia
Macon, Georgia
University of Chicago Hospital Medical Center
Chicago, Illinois
University of Louisville School of Medicine
Louisville, Kentucky
Metropolitan Gastroenterology Group. PC
Chevy Chase, Maryland
Endoscopic Microsurgery Associates PA
Towson, Maryland
MedRACS
Quincy, Massachusetts
Clinical Research Institute of Michigan
Chesterfield, Michigan
Center for Digestive Health
Troy, Michigan
Digestive Health Center
Ocean Springs, Mississippi
St. Louis Center for Clinical Research
St Louis, Missouri
Long Island Clinical Research Associates, LLP
Great Neck, New York
NY Scientific CORP
Hollis, New York
PMG Research of Salisbury
Salisbury, North Carolina
PMG Research of Winston-Salem, LLC
Winston-Salem, North Carolina
Ohio Gastroenterology and Liver
Cincinnati, Ohio
Consultants for Clinical Research
Cincinnati, Ohio
Advanced Research Institute
Ogden, Utah
University of Washington Medical Center
Seattle, Washington
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.